{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:17:53Z","timestamp":1789996673646,"version":"4.0.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,1,22]],"date-time":"2014-01-22T00:00:00Z","timestamp":1390348800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s00415-013-7239-x","type":"journal-article","created":{"date-parts":[[2014,1,21]],"date-time":"2014-01-21T03:45:47Z","timestamp":1390275947000},"page":"579-588","source":"Crossref","is-referenced-by-count":164,"title":["Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy"],"prefix":"10.1007","volume":"261","author":[{"given":"Gyri","family":"Veiby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Kjersti","family":"Daltveit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernt A.","family":"Engelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils Erik","family":"Gilhus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,22]]},"reference":[{"issue":"9","key":"7239_CR1","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1111\/j.1528-1167.2009.02147.x","volume":"50","author":"G Veiby","year":"2009","unstructured":"Veiby G, Daltveit AK, Engelsen BA, Gilhus NE (2009) Pregnancy, delivery, and outcome for the child in maternal epilepsy. Epilepsia 50(9):2130\u20132139","journal-title":"Epilepsia"},{"issue":"2","key":"7239_CR2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1212\/WNL.0b013e3181a6b312","volume":"73","author":"CL Harden","year":"2009","unstructured":"Harden CL, Meador KJ, Pennell PB, Hauser WA, Gronseth GS, French JA et al (2009) Practice parameter update: management issues for women with epilepsy\u2013focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 73(2):133\u2013141","journal-title":"Neurology"},{"issue":"7","key":"7239_CR3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(11)70107-7","volume":"10","author":"T Tomson","year":"2011","unstructured":"Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Sabers A et al (2011) Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 10(7):609\u2013617","journal-title":"Lancet Neurol"},{"issue":"16","key":"7239_CR4","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa0803531","volume":"360","author":"KJ Meador","year":"2009","unstructured":"Meador KJ, Baker GA, Browning N, Clayton-Smith J, Combs-Cantrell DT, Cohen M et al (2009) Cognitive function at 3\u00a0years of age after fetal exposure to antiepileptic drugs. N Engl J Med 360(16):1597\u20131605","journal-title":"N Engl J Med"},{"issue":"Pt 2","key":"7239_CR5","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/brain\/awq352","volume":"134","author":"KJ Meador","year":"2011","unstructured":"Meador KJ, Baker GA, Browning N, Cohen MJ, Clayton-Smith J, Kalayjian LA et al (2011) Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three\u00a0years of age. Brain 134(Pt 2):396\u2013404","journal-title":"Brain"},{"issue":"17","key":"7239_CR6","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1212\/WNL.0b013e318250d824","volume":"78","author":"KJ Meador","year":"2012","unstructured":"Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J et al (2012) Effects of fetal antiepileptic drug exposure: outcomes at age 4.5\u00a0years. Neurology 78(17):1207\u20131214","journal-title":"Neurology"},{"issue":"8","key":"7239_CR7","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1212\/WNL.0b013e31820d62c7","volume":"76","author":"C Nadebaum","year":"2011","unstructured":"Nadebaum C, Anderson VA, Vajda F, Reutens DC, Barton S, Wood AG (2011) Language skills of school-aged children prenatally exposed to antiepileptic drugs. Neurology 76(8):719\u2013726","journal-title":"Neurology"},{"issue":"12","key":"7239_CR8","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1111\/j.1528-1167.2007.01376.x","volume":"48","author":"SV Thomas","year":"2007","unstructured":"Thomas SV, Sukumaran S, Lukose N, George A, Sarma PS (2007) Intellectual and language functions in children of mothers with epilepsy. Epilepsia 48(12):2234\u20132240","journal-title":"Epilepsia"},{"issue":"1","key":"7239_CR9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.yebeh.2008.10.011","volume":"14","author":"J Vinten","year":"2009","unstructured":"Vinten J, Bromley RL, Taylor J, Adab N, Kini U, Baker GA (2009) The behavioral consequences of exposure to antiepileptic drugs in utero. Epilepsy Behav 14(1):197\u2013201","journal-title":"Epilepsy Behav"},{"issue":"4","key":"7239_CR10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1651-2227.2002.tb01663.x","volume":"91","author":"K Wide","year":"2002","unstructured":"Wide K, Henning E, Tomson T, Winbladh B (2002) Psychomotor development in preschool children exposed to antiepileptic drugs in utero. Acta Paediatr 91(4):409\u2013414","journal-title":"Acta Paediatr"},{"issue":"8","key":"7239_CR11","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1111\/epi.12226","volume":"54","author":"G Veiby","year":"2013","unstructured":"Veiby G, Daltveit AK, Schjolberg S, Stoltenberg C, \u00d8yen A, Vollset SE et al (2013) Exposure to antiepileptic drugs in utero and child development\u2014a prospective population-based study. Epilepsia 54(8):1462\u20131472","journal-title":"Epilepsia"},{"key":"7239_CR12","doi-asserted-by":"crossref","unstructured":"Veiby G, Engelsen BA, Gilhus NE (2013) Early child development and exposure to antiepileptic drugs prenatally and through breastfeeding: a prospective cohort study on children of women with epilepsy. JAMA Neurol\u00a070(11):1367\u20131374","DOI":"10.1001\/jamaneurol.2013.4290"},{"issue":"2","key":"7239_CR13","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s00415-012-6662-8","volume":"260","author":"M Rauchenzauner","year":"2013","unstructured":"Rauchenzauner M, Ehrensberger M, Prieschl M, Kapelari K, Bergmann M, Walser G et al (2013) Generalized tonic-clonic seizures and antiepileptic drugs during pregnancy-a matter of importance for the baby? J Neurol 260(2):484\u2013488","journal-title":"J Neurol"},{"issue":"Suppl 1","key":"7239_CR14","first-page":"1","volume":"118","author":"R Cantwell","year":"2011","unstructured":"Cantwell R, Clutton-Brock T, Cooper G, Dawson A, Drife J, Garrod D et al (2011) Saving mothers\u2019 lives: reviewing maternal deaths to make motherhood safer: 2006\u20132008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 118(Suppl 1):1\u2013203","journal-title":"BJOG"},{"issue":"8","key":"7239_CR15","first-page":"979","volume":"66","author":"YH Chen","year":"2009","unstructured":"Chen YH, Chiou HY, Lin HC, Lin HL (2009) Affect of seizures during gestation on pregnancy outcomes in women with epilepsy. Arch Neurol 66(8):979\u2013984","journal-title":"Arch Neurol"},{"issue":"1","key":"7239_CR16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1515\/jpme.1979.7.1.3","volume":"7","author":"K Teramo","year":"1979","unstructured":"Teramo K, Hiilesmaa V, Bardy A, Saarikoski S (1979) Fetal heart rate during a maternal grand mal epileptic seizure. J Perinat Med 7(1):3\u20136","journal-title":"J Perinat Med"},{"issue":"13","key":"7239_CR17","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1111\/j.1471-0528.2009.02354.x","volume":"116","author":"I Borthen","year":"2009","unstructured":"Borthen I, Eide MG, Veiby G, Daltveit AK, Gilhus NE (2009) Complications during pregnancy in women with epilepsy: population-based cohort study. BJOG 116(13):1736\u20131742","journal-title":"BJOG"},{"key":"7239_CR18","doi-asserted-by":"crossref","unstructured":"EURAP Study Group (2006) Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry. Neurology 66(3):354\u2013360","DOI":"10.1212\/01.wnl.0000195888.51845.80"},{"issue":"6","key":"7239_CR19","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1080\/j.1600-0412.2000.079006440.x","volume":"79","author":"R Skjaerven","year":"2000","unstructured":"Skjaerven R, Gjessing HK, Bakketeig LS (2000) Birthweight by gestational age in Norway. Acta Obstet Gynecol Scand 79(6):440\u2013449","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"7239_CR20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.spen.2007.07.003","volume":"14","author":"D Abuelo","year":"2007","unstructured":"Abuelo D (2007) Microcephaly syndromes. Semin Pediatr Neurol 14(3):118\u2013127","journal-title":"Semin Pediatr Neurol"},{"issue":"10","key":"7239_CR21","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.seizure.2009.09.002","volume":"18","author":"M Almgren","year":"2009","unstructured":"Almgren M, Kallen B, Lavebratt C (2009) Population-based study of antiepileptic drug exposure in utero-influence on head circumference in newborns. Seizure 18(10):672\u2013675","journal-title":"Seizure"},{"issue":"2","key":"7239_CR22","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00003081-200606000-00009","volume":"49","author":"DJ Barker","year":"2006","unstructured":"Barker DJ (2006) Adult consequences of fetal growth restriction. Clin Obstet Gynecol 49(2):270\u2013283","journal-title":"Clin Obstet Gynecol"},{"issue":"6","key":"7239_CR23","doi-asserted-by":"crossref","first-page":"e1534","DOI":"10.1542\/peds.2007-2671","volume":"121","author":"JL Cheong","year":"2008","unstructured":"Cheong JL, Hunt RW, Anderson PJ, Howard K, Thompson DK, Wang HX et al (2008) Head growth in preterm infants: correlation with magnetic resonance imaging and neurodevelopmental outcome. Pediatrics 121(6):e1534\u2013e1540","journal-title":"Pediatrics"},{"issue":"2","key":"7239_CR24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1210\/er.2006-0039","volume":"28","author":"P Saenger","year":"2007","unstructured":"Saenger P, Czernichow P, Hughes I, Reiter EO (2007) Small for gestational age: short stature and beyond. Endocr Rev 28(2):219\u2013251","journal-title":"Endocr Rev"},{"issue":"9","key":"7239_CR25","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1474-4422(12)70103-5","volume":"11","author":"T Tomson","year":"2012","unstructured":"Tomson T, Battino D (2012) Teratogenic effects of antiepileptic drugs. Lancet Neurol 11(9):803\u2013813","journal-title":"Lancet Neurol"},{"issue":"17","key":"7239_CR26","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMp1211277","volume":"367","author":"E Colman","year":"2012","unstructured":"Colman E, Golden J, Roberts M, Egan A, Weaver J, Rosebraugh C (2012) The FDA\u2019s assessment of two drugs for chronic weight management. N Engl J Med 367(17):1577\u20131579","journal-title":"N Engl J Med"},{"issue":"3","key":"7239_CR27","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.reprotox.2008.03.001","volume":"25","author":"A Ornoy","year":"2008","unstructured":"Ornoy A, Zvi N, Arnon J, Wajnberg R, Shechtman S, Diav-Citrin O (2008) The outcome of pregnancy following topiramate treatment: a study on 52 pregnancies. Reprod Toxicol 25(3):388\u2013389","journal-title":"Reprod Toxicol"},{"key":"7239_CR28","doi-asserted-by":"crossref","unstructured":"Pickrell WO, Lacey AS, Thomas RH, Smith PE, Rees MI (2013) Weight change associated with antiepileptic drugs. J Neurol Neurosurg Psychiatry 84(7):796\u2013799","DOI":"10.1136\/jnnp-2012-303688"},{"issue":"19","key":"7239_CR29","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1001\/jama.2011.624","volume":"305","author":"D Molgaard-Nielsen","year":"2011","unstructured":"Molgaard-Nielsen D, Hviid A (2011) Newer-generation antiepileptic drugs and the risk of major birth defects. JAMA 305(19):1996\u20132002","journal-title":"JAMA"},{"issue":"8","key":"7239_CR30","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/bdra.23028","volume":"94","author":"LB Holmes","year":"2012","unstructured":"Holmes LB, Hernandez-Diaz S (2012) Newer anticonvulsants: lamotrigine, topiramate and gabapentin. Birth Defects Res A Clin Mol Teratol 94(8):599\u2013606","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"23","key":"7239_CR31","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMoa0907328","volume":"362","author":"J Jentink","year":"2010","unstructured":"Jentink J, Loane MA, Dolk H, Barisic I, Garne E, Morris JK et al (2010) Valproic acid monotherapy in pregnancy and major congenital malformations. N Engl J Med 362(23):2185\u20132193","journal-title":"N Engl J Med"},{"issue":"1","key":"7239_CR32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1528-1167.2012.03625.x","volume":"54","author":"FJ Vajda","year":"2013","unstructured":"Vajda FJ, O\u2019Brien TJ, Lander CM, Graham J, Roten A, Eadie MJ (2013) Teratogenesis in repeated pregnancies in antiepileptic drug-treated women. Epilepsia 54(1):181\u2013186","journal-title":"Epilepsia"},{"issue":"6","key":"7239_CR33","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejmg.2007.08.002","volume":"50","author":"U Kini","year":"2007","unstructured":"Kini U, Lee R, Jones A, Smith S, Ramsden S, Fryer A et al (2007) Influence of the MTHFR genotype on the rate of malformations following exposure to antiepileptic drugs in utero. Eur J Med Genet 50(6):411\u2013420","journal-title":"Eur J Med Genet"},{"issue":"3","key":"7239_CR34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ajmg.c.30314","volume":"157","author":"BJ Wlodarczyk","year":"2011","unstructured":"Wlodarczyk BJ, Palacios AM, Chapa CJ, Zhu H, George TM, Finnell RH (2011) Genetic basis of susceptibility to teratogen induced birth defects. Am J Med Genet C Semin Med Genet 157(3):215\u2013226","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"2","key":"7239_CR35","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.reprotox.2012.05.004","volume":"34","author":"M Cassina","year":"2012","unstructured":"Cassina M, Salviati L, Di GE, Clementi M (2012) Genetic susceptibility to teratogens: state of the art. Reprod Toxicol 34(2):186\u2013191","journal-title":"Reprod Toxicol"},{"issue":"10","key":"7239_CR36","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/archneurol.2011.133","volume":"68","author":"LB Holmes","year":"2011","unstructured":"Holmes LB, Mittendorf R, Shen A, Smith CR, Hernandez-Diaz S (2011) Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations. Arch Neurol 68(10):1275\u20131281","journal-title":"Arch Neurol"},{"issue":"1","key":"7239_CR37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1468-1331.2006.01538.x","volume":"14","author":"JM Hoff","year":"2007","unstructured":"Hoff JM, Daltveit AK, Gilhus NE (2007) Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising care. Eur J Neurol 14(1):38\u201343","journal-title":"Eur J Neurol"},{"issue":"9","key":"7239_CR38","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1034\/j.1600-0412.2002.810905.x","volume":"81","author":"J Skomsvoll","year":"2002","unstructured":"Skomsvoll J, Ostensen M, Baste V, Irgens L (2002) Validity of a rheumatic disease diagnosis in the Medical Birth Registry of Norway. Acta Obstet Gynecol Scand 81(9):831\u2013834","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"8","key":"7239_CR39","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1471-0528.2011.03004.x","volume":"118","author":"I Borthen","year":"2011","unstructured":"Borthen I, Eide M, Daltveit A, Gilhus N (2011) Obstetric outcome in women with epilepsy: a hospital-based, retrospective study. BJOG 118(8):956\u2013965","journal-title":"BJOG"},{"issue":"5","key":"7239_CR40","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2125.2008.03102.x","volume":"65","author":"A Engeland","year":"2008","unstructured":"Engeland A, Bramness JG, Daltveit AK, Ronning M, Skurtveit S, Furu K (2008) Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004\u20132006. Br J Clin Pharmacol 65(5):653\u2013660","journal-title":"Br J Clin Pharmacol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-013-7239-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-013-7239-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-013-7239-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T07:48:00Z","timestamp":1716450480000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-013-7239-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,22]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["7239"],"URL":"https:\/\/doi.org\/10.1007\/s00415-013-7239-x","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,22]]}}}